Muramyl Dipeptide Administration Delays Alzheimer’s Disease Physiopathology via NOD2 Receptors

Alzheimer’s disease (AD) is the most common form of dementia in the world. The prevalence is steadily increasing due to an aging population and the lack of effective treatments. However, modulation of innate immune cells is a new therapeutic avenue, which is quite effective at delaying disease onset...

Descripción completa

Detalles Bibliográficos
Autores principales: Piec, Pierre-Alexandre, Pons, Vincent, Préfontaine, Paul, Rivest, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321587/
https://www.ncbi.nlm.nih.gov/pubmed/35883683
http://dx.doi.org/10.3390/cells11142241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321587/
https://www.ncbi.nlm.nih.gov/pubmed/35883683
http://dx.doi.org/10.3390/cells11142241

Ejemplares similares